$TECX News

Raymond James Upgrades Tectonic Therapeutic to Strong Buy, Raises Price Target to $81

TECTONIC THERAPEUTIC INC (NASDAQ:TECX) Q1 Loss Wider Than Expected, Pipeline Progress Provides Key Catalyst

Tectonic Therapeutic Q1 EPS $(1.34) Misses $(1.18) Estimate

Tectonic Therapeutic: A $1B+ Opportunity Hinges On Upcoming Phase 2

Stifel Initiates Coverage On Tectonic Therapeutic with Buy Rating, Announces Price Target of $75

Tectonic Therapeutic, Inc. (TECX) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Tectonic Therapeutic to Participate in March Investor Conferences

Tectonic Therapeutic Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Tectonic Therapeutic Q4 EPS $(1.03) Beats $(1.10) Estimate

Tenax Therapeutics: Some Future Potential

Tectonic Therapeutic Spotlights TX2100 in HHT as First-in-Human Phase 1 Dosing Begins

Tectonic Therapeutic Appoints Independent Director Of Moderna François Nader To Independent Director And Chair Of Company Board Effective April 1st

Daniel Lochner Bought 70% More Shares In Tectonic Therapeutic

Here's How Much You Would Have Made Owning Tectonic Therapeutic Stock In The Last 5 Years

Tectonic Therapeutic to Host Virtual KOL Event and Discussion of TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia, on February 24, 2026

12 Health Care Stocks Moving In Tuesday's After-Market Session

Truist Securities Maintains Buy on Tectonic Therapeutic, Lowers Price Target to $60

Tectonic Therapeutic (TECX): LifeSci Capital Reiterates Buy Rating

Tectonic Therapeutic to Participate in December Investor Conferences

Tectonic Therapeutic Announces Third Quarter 2025 Financial Results and Recent Business Highlights